SEC Comment Letter 0000000000-23-004680 to Moderna, Inc. (MRNA) (CIK 0001682852) (MRNA)
Moderna, Inc. (MRNA) (CIK 0001682852)
Date: May 5, 2023 · CIK: 0001682852 · Accession: 0000000000-23-004680
AI Filing Summary & Sentiment
Letter
United States securities and exchange commission logo May 5, 2023 James Mock Chief Financial Officer Moderna, Inc. 200 Technology Square Cambridge, MA 02139 Re:Moderna, Inc. Form 10-K for the fiscal year ended December 31, 2022 Filed February 24, 2023 File No. 1-38753 Dear James Mock: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
May 5, 2023
James Mock
Chief Financial Officer
Moderna, Inc.
200 Technology Square
Cambridge, MA 02139
Re:Moderna, Inc.
Form 10-K for the fiscal year ended December 31, 2022
Filed February 24, 2023
File No. 1-38753
Dear James Mock:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences